800.277.1193
PhoneDePuy ASR Fails in more than a Quarter of Cases
According to the U.K medical registry, the ASR hip implant is removed or replaced 29% of the time after 6 years versus a 9.5% failure rate for metal-on-metal implants in general.
How Did This Happen?
As the number of legal actions against DePuy Orthopedics over the failure of their ASR hip implants continue to increase, consumers understandably are wondering how this could have happened in the first place. Aren't such products supposed to be approved by the Food and Drug Administration before they are allowed on to the market? And isn't such approval supposed to be granted only after extensive testing?
A Child's Exposure To An SSRI During Pregnancy May Lead To Developmental Delays
During birth, or shortly thereafter, infants may suffer from a hypoxic event wherein inadequate oxygen is provided to major organs. Unfortunately, this is one of the most common problems for a pediatric physician. Children who have been exposed to medications such as SSRIs during pregnancy, most often during the third trimester, may experience withdrawal symptoms mirroring forms of hypoxia. Gray matter damage on brain MRIs of children who have experienced a hypoxic event predicts adverse motor outcomes at age
At Conference, Merck Responds to FDA Inquiries About Fosamax
ADELPHI, MD
At today's FDA Panel conference on the long term use of osteoporosis drugs like Fosamax, presenter Arthur C. Santora MD, PhD, speaking for Merck, the drug manufacturer, attempted to convince the panel that limits on the duration of the drugs use were not necessary. However, Dr. Santora did admit that drug "holiday" (meaning a temporary interruption in usage) may be considered for patients who are no longer considered to have a sufficiently high fracture risk.
FDA Presents Data for Long-Term Fosamax Use
ADELPHI, MD
In the early morning session of today's FDA Panel conference on the long term use of bisphosphonates, like the drug Fosamax, the FDA's Lead Medical Officer Fatmatta Kuyateh, M.D. indicated that radiographic findings consistent with atypical femur fractures case have been associated with bisphosphonate use.
Prescription Drug User Fee Act (PDUFA): friend or foe?
Drug companies to pay the FDA $100 million in additional fees. The upside (or is it?): 2,000 regulators get to keep their job and new drugs will continue to funnel into the market. The downside: the FDA will increase its staff and drug companies get additional face time during the drug review process. The last PDUFA reauthorization in 2007 was highly disputed when the FDA failed to monitor dangerous drugs such as Vioxx.
What Does It Take?
by
K.J. McElrath
What constitutes proof of a conspiracy? And what does it take to demonstrate that a toxic substance actually does cause disease?
It is no secret – at least to those who are paying attention – that in the U.S. (and increasingly, around the world), rights and protections for natural human beings are being stripped away while at the same time, corporations are given more rights, more protections – and a whole lot less accountability.
LP Attorney Clay Mitchell Featured In Keenan Blog
In reference to the well known jury selection strategy known as the Reptile Theory, trial attorney Clay Mitchell is highlighted as a "Superstar" in relation to a recent multi-million dollar jury verdict.
How Do You Fight Nature?
by
K.J. McElrath
Most asbestos exposure is the result of industrial use as well as construction, ship building, electronics, automotive manufacture and servicing, aviation...the list goes on and on and on.
Actos – The Next Asbestos?
Although asbestos continues to be a source of illness – and the litigation that results from it – there is seemingly no end to product liability.
The Recalled DePuy ASR Hip - When Did DePuy and Johnson & Johnson know they were defective?
By Levin Papantonio Attorney Daniel Nigh
I’ve spoken with a few prospective clients who have felt bad for DePuy and Johnson & Johnson. They thought that the corporations had good intentions with these recalled hips and just all of a sudden found out these hips were bad and immediately recalled them. However, that couldn’t be further from the truth. These major corporations put profit over the safety of the patients.
FDA Complaints Regarding the Recalled DePuy Hip (ASR) and All Metal on Metal Hips Continue to Mount Up
Berry Meier, of the New York Times, has reported yet another installment on the defective DePuy hips and on Metal on Metal hips in general.
Florida Supreme Court lets Engle progeny case jury award stand
In the first case of the so-called Engle progeny to reach the Florida Supreme Court, the court has declined to review a lower court’s decision upholding $3.3 million in compensatory damages and $25 million in punitive damages for the widow of a smoker. (R.J. Reynolds Tobacco Co. v. Martin, No. SC11-483 (Fla. July 19, 2011).)
Florida Supreme Court Blocks Tobacco Appeal
By The News Service of Florida, Herald-Tribune
TALLAHASSEE
In a decision with huge implications for lawsuits against tobacco companies, the Florida Supreme Court on Tuesday declined to hear R.J. Reynolds’ appeal of a $28.3 million verdict in the death of a Panhandle smoker.
Peter Mougey quoted in Wall Street Journal on (Non) Binding Arbitration
Disputes between investors and brokerages are handled by arbitrators. But their rulings aren't always the end of the line. Read More
LP Wins Tobacco Appeal
Court ruling may be big help for smoker plaintiffs
Law.com
Legal / Law Matters
Jose Pagliery, Daily Business Review, On Thursday December 16, 2010, 3:02 am
German Der Spiegel Covers Papantonio Visit on BP Oil Spill
The oil seems disappeared in the gulf of Mexico, now argues the lawyers about how many billions of dollars BP will pay to the victims of the environmental disaster.
Levin Papantonio Attorney Brian Barr selected by Judge to Oversee BP claims
Pensacola attorney Brian Barr is one of only four lawyers chosen by a federal judge to oversee thousands of claims against BP, Halliburton and Transocean for damages caused by the Gulf oil spill.